This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aldwell, F. E.
Right arrow Articles by Orme, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aldwell, F. E.
Right arrow Articles by Orme, I. M.

 Previous Article

Infection and Immunity, March 2005, p. 1903-1905, Vol. 73, No. 3
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.3.1903-1905.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Mice Fed Lipid-Encapsulated Mycobacterium bovis BCG Are Protected against Aerosol Challenge with Mycobacterium tuberculosis

Frank E. Aldwell,1* Lise Brandt,2,{dagger} Clare Fitzpatrick,1 and Ian M. Orme2

Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand,1 Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado2

Received 22 September 2004/ Returned for modification 2 November 2004/ Accepted 11 November 2004

Mice that consumed a single dose of 107 lipid-encapsulated Mycobacterium bovis BCG bacilli showed significant pulmonary and systemic protection against aerosol challenge with M. tuberculosis H37Rv. As an extension of previous challenge studies with virulent strains of M. bovis, this report describes a reduction in M. tuberculosis infection in mice vaccinated orally with lipid-encapculated BCG comparable to that observed in mice vaccinated subcutaneously with BCG. These results are consistent with the induction of tuberculin-specific cell-mediated immune responses.

* Corresponding author. Mailing address: Department of Microbiology and Immunology, University of Otago, P.O. Box 56, Dunedin, New Zealand. Phone: 64 34795931. Fax: 64 34798576. E-mail: frank.aldwell{at}stonebow.otago.ac.nz.

Editor: W. A. Petri, Jr.

{dagger} Present address: KLIFO A/S, Copenhagen Science Park, Symbion, 2100 Copenhagen OE, Denmark.

Infection and Immunity, March 2005, p. 1903-1905, Vol. 73, No. 3
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.3.1903-1905.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Hwang, S.-A., Actor, J. K. (2009). Lactoferrin modulation of BCG-infected dendritic cell functions. Int Immunol 21: 1185-1197 [Abstract] [Full Text]  
  • Clark, S., Cross, M. L., Nadian, A., Vipond, J., Court, P., Williams, A., Hewinson, R. G., Aldwell, F. E., Chambers, M. A. (2008). Oral Vaccination of Guinea Pigs with a Mycobacterium bovis Bacillus Calmette-Guerin Vaccine in a Lipid Matrix Protects against Aerosol Infection with Virulent M. bovis. Infect. Immun. 76: 3771-3776 [Abstract] [Full Text]  
  • Nol, P., Palmer, M. V., Waters, W. R., Aldwell, F. E., Buddle, B. M., Triantis, J. M., Linke, L. M., Phillips, G. E., Thacker, T. C., Rhyan, J. C., Dunbar, M. R., Salman, M. D. (2008). EFFICACY OF ORAL AND PARENTERAL ROUTES OF MYCOBACTERIUM BOVIS BACILLE CALMETTE-GUERIN VACCINATION AGAINST EXPERIMENTAL BOVINE TUBERCULOSIS IN WHITE-TAILED DEER (ODOCOILEUS VIRGINIANUS): A FEASIBILITY STUDY. J Wildl Dis 44: 247-259 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»